Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Zydus Lifesciences bags USFDA nod for Vitamin B12 injection Cyanocobalamin

Ruchika Sharma18 April 2022 12:17 PM IST

The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat.

Sinovac, Sinopharm Omicron-specific vaccine candidates approved for clinical trial in Hong Kong

Ruchika Sharma18 April 2022 11:55 AM IST

The Sinopharm candidates will be tested as boosters in adults who have already received two or three vaccine doses, CNBG said.

USFDA extends review of REGEN-COV to treat, prevent COVID-19: Regeneron Pharma

Ruchika Sharma18 April 2022 10:00 AM IST

REGEN-COV (casirivimab and imdevimab) is a cocktail of two monoclonal antibodies designed specifically to block infectivity of SARS-CoV-2 using...

GSK to acquire Sierra Oncology for USD 1.9 billion

Ruchika Sharma17 April 2022 11:00 AM IST

Under the terms of the agreement, the acquisition will be effected through a one-step merger in which the shares of Sierra Oncology outstanding will...

Sandoz launches generic equivalent of AbbVie eyedrop Combigan in US

Ruchika Sharma17 April 2022 10:15 AM IST

"Fixed combinations of medicines to treat ocular hypertension can offer patients enhanced convenience, improved adherence, reduced exposure to...

Pharma industry must focus on generic, better link between input and output: Piyush Goyal

Ruchika Sharma17 April 2022 10:00 AM IST

The minister said, "it's extremely important that we focus not only on our strengths in the generic sector but also ensure our backward and forward...

Pfizer to seek USFDA nod for COVID booster for healthy 5- to 11-year-olds

Ruchika Sharma17 April 2022 9:45 AM IST

The Pfizer shots are the only vaccine available to US children.

Poorer nations refuse millions of AstraZeneca COVID vaccines from COVAX: Document

Ruchika Sharma17 April 2022 9:00 AM IST

Countries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson and Johnson, Pfizer...

Bristol Myers Squibb, Nektar halt Bempegaldesleukin, Opdivo cocktail trials for cancer treatment

Ruchika Sharma16 April 2022 2:57 PM IST

Princeton: Nektar Therapeutics and Bristol Myers Squibb have announced that based on results from pre-planned analyses of two...

Merck Pneumococcal vaccine gets USFDA Breakthrough Therapy Designation

Ruchika Sharma16 April 2022 12:47 PM IST

The Breakthrough Therapy Designation is an FDA program designed to expedite the development and review of products intended for serious or...

Hyderabad: KT Rama Rao inaugurates Sahajanand Medical Technologies stent manufacturing facility

Ruchika Sharma16 April 2022 12:20 PM IST

This will be the second manufacturing unit of SMT that will manufacture 1.2 million stents and 2 million catheters when in full capacity.

Fourfold increase in investigational new drugs applications in India: DCGI

Ruchika Sharma16 April 2022 11:26 AM IST

Dr VG Somani said that the "Made in India" drugs will make a difference and hit the world in the coming years.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok